222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details

臨床試験数 : 285 / 薬物数 : 285 - (DrugBank : 108) / 標的遺伝子数 : 62 - 標的パスウェイ数 : 191

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-IPR-17011386	2017-06-01	2017-05-12	Study on the Effect and Mechanism of Interleukin - 2 in the Treatment of Idiopathic Membranous Nephr ...	Study on the Effect and Mechanism of Interleukin - 2 in the Treatment of Idiopathic Membranous Nephr ...	Membranous Nephropathy	treatment group:oral CsA, glucosteroid aInterleukin 2nd;Control group:oral CsA and glucosteroid;	Shijiazhuang kidney disease hospital Limited company	NULL	Recruiting	18	60	Both	treatment group:50;Control group:50;		China
2	ChiCTR-IPR-16008527	2016-06-01	2016-05-24	Rituximab in the treatment of refractory membranous nephropathy: a multicenter, randomized, controll ...	Rituximab in the treatment of resistant membranous nephropathy: a multicenter, randomized, controlle ...	Membranous nephropathy	CsAgroup:oral CsAand glucosteroid;RTXgroup:intravenous RTX;CTX:Intravenous cyclophosphamideand gluco ...	Ruijin Hospital, affiliated to Shanghai Jiaotong University, School of medicine	NULL	Completed	18	70	Both	CsA group:60;RTX group:60;CTX:60;	Phase 4	China

First Previous1Next Last